Participants:18–64 years · 65+ years
Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Clazakizumab

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Thermal burn

Recruiting

InvestigationalNo placebo

Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

InvestigationalNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts

Contact Research Centre

Crohn's disease

Recruiting

Registered drugNo placebo

Study on Transmural Healing in Patients with Moderate to Severe Crohn's Disease Using Upadacitinib and Drug Combination

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Influenza

Recruiting

Registered drugNo placebo

Study on Baloxavir Marboxil for Children with Influenza

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Baloxavir Marboxil

Contact Research Centre

Pneumococcal immunisation

Not yet recruiting

Registered drugNo placebo

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate

Contact Research Centre

Pneumococcal immunisation

Not yet recruiting

Registered drugNo placebo

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate

Contact Research Centre

Find therapies in clinical trials near you

27 trials match your criteria

Crohn's disease

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Crohn's disease

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Acute respiratory failure

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Coeliac disease

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Arteriosclerosis

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Colitis ulcerative

Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

Crohn's disease

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Thermal burn

Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

Crohn's disease

Study on Transmural Healing in Patients with Moderate to Severe Crohn's Disease Using Upadacitinib and Drug Combination

Influenza

Study on Baloxavir Marboxil for Children with Influenza

Pneumococcal immunisation

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Pneumococcal immunisation

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.